Kazuo Hatano

机构：Astellas Pharma (Japan), Kyoto Prefectural University of Medicine

发表论文 188 篇 · 总被引 4950 次 · h-index 27

代表论文

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma (2013 · Lung Cancer · 被引 261)
Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (2014 · International Journal of Radiation Oncology*Biology*Physics · 被引 104)
Phase II Study of Oral S-1 and Concurrent Radiotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer (2010 · International Journal of Radiation Oncology*Biology*Physics · 被引 77)
A Consensus-based Guideline Defining Clinical Target Volume for Primary Disease in External Beam Radiotherapy for Intact Uterine Cervical Cancer (2011 · Japanese Journal of Clinical Oncology · 被引 64)
Current status of intensity‐modulated radiation therapy for prostate cancer: History, clinical results and future directions (2019 · International Journal of Urology · 被引 42)
Impact of Intraluminal Brachytherapy on Survival Outcome for Radiation Therapy for Unresectable Biliary Tract Cancer: A Propensity-Score Matched-Pair Analysis (2014 · International Journal of Radiation Oncology*Biology*Physics · 被引 37)